Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-035435
Filing Date
2024-03-22
Accepted
2024-03-22 16:51:11
Documents
1
Period of Report
2024-03-22

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 28576
  Complete submission text file 0000950170-24-035435.txt   30210
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

EIN.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SAN FRANCISCO CA 94080
Business Address
EMSTER KURT VON (Reporting) CIK: 0001252524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36500 | Film No.: 24775953